Web Results


McNeil Consumer Healthcare is an American medicals products company belonging to the Johnson & Johnson healthcare products group. Contents. [hide]. 1 History; 2 McNeil Nutritionals; 3 Johnson & Johnson Merck Joint Venture; 4 1982 Chicago Tylenol murders; 5 2010 Product recall; 6 References; 7 External links ...


FORT WASHINGTON, PA, (September 28, 2011) – McNEIL-PPC, Inc. and its affiliate McNeil MMP, LLC (McNEIL) announced today that they have completed the acquisition of full ownership of the Johnson & Johnson•Merck Consumer Pharmaceuticals Co. joint venture in the United States from Merck Sharp & Dohme Corp.


J&J fails in request to exclude two experts for the plaintiff in bellwether litigation alleging liver damage from indicated doses of Tylenol Extra Strength. The decision represents the second blow in less than a month in J&J's efforts to exclude plaintiff's evidence from the trial. Consumer Legal Issues. Bookmark. 06 Jan 2016 ...


Mar 10, 2015 ... PHILADELPHIA – McNeil-PPC Inc. pleaded guilty today to violating the federal Food, Drug and Cosmetic Act (FDCA) with regard to infants' and children's liquid medications, including Infants' Tylenol, Children's Tylenol and Children's Motrin. McNeil, a wholly owned subsidiary of Johnson & Johnson, was ...


Nov 8, 2013 ... Johnson & Johnson Healthcare Products, Division of McNEIL-PPC, Inc. - Get up- to-date information on Johnson & Johnson Healthcare Products, Division of McNEIL-PPC, Inc. side effects, uses, dosage, overdose, pregnancy, alcohol and more. Learn more about Johnson & Johnson Healthcare Products, ...


Johnson & Johnson Consumer Inc. produces and markets over-the-counter (OTC ) products to families, children, healthcare professionals, and other consumers in the United States and internationally. The company offers TYLENOL product line that consists of products across various pain categories, including arthritis pain, ...


Worldwide distributor of dental, medical, and veterinary healthcare products, services and supplies.


Drug information for Rolaids Multi-Symptom by McNeil Consumer Healthcare Div . McNeil-PPC, Inc. Includes: facts, uses, warnings, directions and more.


Jul 22, 2014 ... McNeilPPC, Inc., appeals from the order of January 6, 2012, entering final judgment for plaintiffs/appellees for $10 million, plus statutory post-judgment interest, in this pharmaceutical failure to warn case. After careful review, we affirm . The trial court has aptly summarized the facts of this case as follows:.